Specificities & Challenges in Development Strategy for ATMPs in the EU
Florence Bine-Sheck, Senior Medical Director at VCLS, shares her insights on the clinical and regulatory aspects of ATMP development in…
A Nonclinical Perspective on the Cell, Gene & Immunotherapy Need-to-Know Characteristics
After a brief look at the current European Guidelines for Advanced Therapy Medicinal Products (ATMPs), this presentation will go through…
Clinical trials with ATMPs in Europe: a focus on GMO specificities
Advanced Therapy Medicinal Products (ATMPs) are an innovative type of medicines for human use, based on genes, cells or tissues.…